Chevy Chase Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-601,153
Closed -$59.7M 1190
2019
Q3
$59.7M Sell
601,153
-19,593
-3% -$1.86M 0.24% 95
2019
Q2
$57.4M Sell
620,746
-2,782
-0.4% -$264K 0.24% 97
2019
Q1
$59M Buy
623,528
+8,000
+1% +$700K 0.24% 96
2018
Q4
$39.5M Sell
615,528
-25,232
-4% -$1.86M 0.19% 121
2018
Q3
$57.3M Sell
640,760
-12,902
-2% -$1.14M 0.24% 94
2018
Q2
$51.9M Sell
653,662
-33,266
-5% -$2.76M 0.23% 101
2018
Q1
$61.3M Sell
686,928
-42,582
-6% -$4.09M 0.27% 91
2017
Q4
$76.1M Sell
729,510
-5,433
-0.7% -$613K 0.33% 70
2017
Q3
$107M Buy
734,943
+10,307
+1% +$1.4M 0.49% 44
2017
Q2
$94.1M Buy
724,636
+4,233
+0.6% +$519K 0.45% 50
2017
Q1
$89.6M Buy
720,403
+22,612
+3% +$2.71M 0.44% 48
2016
Q4
$80.8M Buy
697,791
+6,531
+0.9% +$727K 0.43% 54
2016
Q3
$72.3M Sell
691,260
-2,431
-0.4% -$263K 0.4% 60
2016
Q2
$68.4M Buy
693,691
+2,392
+0.3% +$247K 0.38% 59
2016
Q1
$69.2M Buy
691,299
+39,243
+6% +$4.04M 0.4% 58
2015
Q4
$78.1M Buy
652,056
+363
+0.1% +$42K 0.46% 55
2015
Q3
$70.5M Buy
651,693
+21,696
+3% +$2.69M 0.44% 56
2015
Q2
$72.9M Buy
629,997
+2,235
+0.4% +$256K 0.44% 54
2015
Q1
$72.4M Buy
627,762
+22,670
+4% +$2.71M 0.44% 53
2014
Q4
$67.7M Sell
605,092
-5,569
-0.9% -$587K 0.42% 51
2014
Q3
$57.9M Buy
610,661
+36,272
+6% +$3.27M 0.37% 58
2014
Q2
$49.3M Sell
574,389
-19,977
-3% -$1.52M 0.34% 69
2014
Q1
$41.5M Sell
594,366
-8,586
-1% -$680K 0.3% 83
2013
Q4
$50.9M Buy
602,952
+9,668
+2% +$765K 0.37% 62
2013
Q3
$45.7M Buy
593,284
+5,282
+0.9% +$370K 0.37% 64
2013
Q2
$34.4M Buy
+588,002
New +$35.4M 0.3% 80

Other funds holding CELG

Chevy Chase Trust's CELG Position: Q4 2019 in Review

Chevy Chase Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 601,153 shares — an estimated $59.7M sold.

Chevy Chase Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $107M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Chevy Chase Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Chevy Chase Trust sold 601,153 Celgene Corp shares in Q4 2019, an estimated $59.7M.
  • Chevy Chase Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Chevy Chase Trust's Celgene Corp position peaked at $107M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Chevy Chase Trust's 13F filing for Q4 2019, filed 12 Feb 2020.